DuPont Will Likely Be Down, but Not Out

You may know that giant agricultural products and chemicals manufacturer DuPont (NYSE: DD  ) dates its formation to the Jefferson administration, when it set up shop in eastern Pennsylvania as a gunpowder manufacturer. Despite that heritage, however, the company is unlikely to shoot the lights out when it reports its earnings on Tuesday.

Analysts who follow the company currently expect its per-share earnings for the quarter to come in at about $0.47 per share, a nearly 32% drop from the $0.69 per share for the second quarter of 2011. Three months ago the Wall Streeters anticipated earnings for the third quarter of $0.70 a share. As time passed, however, that consensus expectation declined to $0.55 about a month ago, before being reduced to its current level.

The factors to watch
While the company will obviously provide far more specific information in its earnings release and on its call, it's nevertheless possible to wager some of the issues that might be responsible for the anticipated earnings decline. Obviously DuPont, like most international marketers, will be affected by the across-the-board global economic slowdown, as well as by a likely increase in its tax rate. In addition, it has faced higher energy and raw materials expenses vis-a-vis those of a year ago.

Despite its likely earnings dip, I continue to consider DuPont a solid, well-managed company. As is the case with Monsanto (NYSE: MON  ) , which used to sport the slogan "Better living through chemistry," DuPont is making steady progress toward increasing the dominance of its agricultural and food-related operations. In May 2011, for instance, it paid $6.3 billion to acquire Danisco, a Copenhagen-based manufacturer of enzyme and specialty food ingredients.

Up to its neck in agriculture
In the second quarter of this year, the company's agricultural unit accounted for $3.4 billion of its $11 billion in total revenue. And thanks to the Danisco purchase, nutrition and health increased a whopping 82% year over year to $0.9 billion. Performance chemicals held onto second place among DuPont's segments, generating $2 billion in revenues for the quarter.

During the third quarter, the company continued to undergo a major alteration. In late August it was announced that The Carlyle Group (Nasdaq: CG  ) , a global alternative asset manager would acquire DuPont Performance Coatings for $4.9 billion in cash. The unit is a significant factor in the worldwide manufacture of vehicle and industrial coatings. While the transaction is anticipated to be consummated in early 2013, the coatings unit and its 11,000 employees are expected to contribute about $4 billion to DuPont's revenues in 2012.

Perhaps because DuPont and the aforementioned Monsanto are becoming progressively more similar, the two have become involved in a skirmish in the U.S. courts. During the past summer, a U.S. District Court in St. Louis awarded the latter company $1 billion in damages in a suit involving its claim that DuPont had illegally infringed on its Roundup Ready soybean patent. DuPont's response to the judgment was that, "There were several fundamental errors in the case, which deprived the jury of important facts and arguments and leld to the disappointing outcome." DuPont further said that it "will appeal at the earliest possible opportunity and expects to overturn the verdict."

Solar strength
On another front, DuPont -- like Chevron (NYSE: CVX  ) the second-largest U.S.-based integrated oil and gas company -- is involved in the manufacture and use of solar energy. Just last week, the company announced that it is "expanding its use of solar energy with the completion of a new 8-acre, 1.3 megawatt (MW) solar array at its Parlin, N.J., manufacturing facility." Further, according to the company, "this brings the total solar energy generated from the 10 existing DuPont solar installations to more than 3 MW, helping to further the company's aim to reduce global dependence on fossil fuels."

DuPont will be followed on the chemicals companies' earnings release stage on Thursday by Dow Chemical (NYSE: DOW  ) . In the meantime, however, I'd urge Fools not to become forlorn over DuPont's likely earnings decline. As I indicated, the company remains solid. On that basis alone, it's a wise selection for inclusion on My Watchlist.

Which stocks can you look to in these uncertain times? Check out our free report "These Could Skyrocket After the 2012 Presidential Election." Barack Obama and Mitt Romney have competing visions for getting America back on track, but The Motley Fool will have you prepared to profit -- no matter who wins! Download your copy now, for free, and discover hidden ways to profit from the election.

David Lee Smith and The Motley Fool have no positions in the stocks mentioned above. Motley Fool newsletter services recommend Chevron and Monsanto. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (2) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On October 23, 2012, at 1:54 AM, funfundvierzig wrote:

    The federal jury verdict on Aug. 1, 2012 and $1 billion award exposed not only DuPont's unethical and willful attempt to steal and use Monsanto's patent-protected superior seed know-how, but DuPont's embarrassing lack of innovation. Monsanto's attorneys cogently laid out the attempts of DuPont Management to cover up their failure to create and commercialise their own GM seed trait to compete with the industry leader, Monsanto. That trait known as DuPont OptimumGAT cannot be planted on an alone-basis by farmers in their fields "without risk."

    ...funfun..

  • Report this Comment On October 23, 2012, at 2:07 AM, funfundvierzig wrote:

    Speaking of DuPont's lack of innovation and issues which might be responsible for the sharp earnings decline in Q3 2012:

    DuPont's much touted "innovation" in lawn herbicides--Imprelis.

    This falsely, if not fraudulently marketed "very environmentally friendly" DuPont weed-killer turned serial tree-killer has laid to waste hundreds of thousands of mature landscaping trees nationwide, and particularly in the mid-west. Imprelis has triggered thousands of costly claims and hundreds of lawsuits in federal and state courts. The burgeoning costs of the ensuing litigation and claims caused by Imprelis, now banned by the U. S. EPA, will weigh on earnings for many quarters to come. Total ultimate costs may reach $1 to $2 billion in the opinion of the undersigned retail investor (with long and short positions in DD) ...funfun..

Add your comment.

DocumentId: 2069581, ~/Articles/ArticleHandler.aspx, 4/19/2014 2:19:42 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement